Inhibikase Therapeutics Market Cap 2019-2024 | IKT

Inhibikase Therapeutics market cap as of November 10, 2024 is $0.02B.

Inhibikase Therapeutics market cap history and chart from 2019 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

Inhibikase Therapeutics Market Cap 2019-2024 | IKT

Inhibikase Therapeutics market cap history and chart from 2019 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.